skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EBSCO_MEDLINE Complete（医学期刊全文数据库） remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Maximized Inter-Class Weighted Mean for Fast and Accurate Mitosis Cells Detection in Breast Cancer Histopathology Images
Maximized Inter-Class Weighted Mean for Fast and Accurate Mitosis Cells Detection in Breast Cancer Histopathology Images
Material Type:
Artigo 		Adicionar ao Meu Espaço

Maximized Inter-Class Weighted Mean for Fast and Accurate Mitosis Cells Detection in Breast Cancer Histopathology Images

Nateghi, Ramin ; Danyali, Habibollah ; Helfroush, Mohammad Sadegh

Journal of medical systems, 2017-09, Vol.41 (9), p.146-146, Article 146 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
2
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer

Li, Xiaoxian ; Yang, Jing ; Peng, Limin ; Sahin, Aysegul A. ; Huo, Lei ; Ward, Kevin C. ; O’Regan, Ruth ; Torres, Mylin A. ; Meisel, Jane L.

Breast cancer research and treatment, 2017-01, Vol.161 (2), p.279-287 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
3
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed

den Brok, Wendie D. ; Speers, Caroline H. ; Gondara, Lovedeep ; Baxter, Emily ; Tyldesley, Scott K. ; Lohrisch, Caroline A.

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.549-556 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
4
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Muenst, S. ; Schaerli, A. R. ; Gao, F. ; Däster, S. ; Trella, E. ; Droeser, R. A. ; Muraro, M. G. ; Zajac, P. ; Zanetti, R. ; Gillanders, W. E. ; Weber, W. P. ; Soysal, S. D.

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.15-24 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
5
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

Cimino-Mathews, Ashley, MD ; Thompson, Elizabeth, MD, PhD ; Taube, Janis M., MD ; Ye, Xiaobu, MD ; Lu, Yao, MS ; Meeker, Alan, PhD ; Xu, Haiying, BS ; Sharma, Rajni, PhD ; Lecksell, Kristen, MS ; Cornish, Toby C., MD, PhD ; Cuka, Nathan, MD ; Argani, Pedram, MD ; Emens, Leisha A., MD

Human pathology, 2016-01, Vol.47 (1), p.52-63 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Murray Brunt, Adrian ; Haviland, Joanne S ; Wheatley, Duncan A ; Sydenham, Mark A ; Alhasso, Abdulla ; Bloomfield, David J ; Chan, Charlie ; Churn, Mark ; Cleator, Susan ; Coles, Charlotte E ; Goodman, Andrew ; Harnett, Adrian ; Hopwood, Penelope ; Kirby, Anna M ; Kirwan, Cliona C ; Morris, Carolyn ; Nabi, Zohal ; Sawyer, Elinor ; Somaiah, Navita ; Stones, Liba ; Syndikus, Isabel ; Bliss, Judith M ; Yarnold, John R ; Alhasso, Abdulla ; Armstrong, Anne ; Bliss, Judith ; Bloomfield, David ; Bowen, Jo ; Brunt, Murray ; Chan, Charlie ; Chantler, Hannah ; Churn, Mark ; Cleator, Susan ; Coles, Charlotte ; Donovan, Ellen ; Goodman, Andy ; Griffin, Susan ; Haviland, Jo ; Hopwood, Penny ; Kirby, Anna ; Kirk, Julie ; Kirwan, Cliona ; MacLennan, Marjory ; Morris, Carolyn ; Nabi, Zohal ; Sawyer, Elinor ; Sculphur, Mark ; Sinclair, Judith ; Somaiah, Navita ; Stones, Liba ; Sydenham, Mark ; Syndikus, Isabel ; Tremlett, Jean ; Venables, Karen ; Wheatley, Duncan ; Yarnold, John

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters

Hashmi, Atif Ali ; Hashmi, Kashif Ali ; Irfan, Muhammad ; Khan, Saadia Mehmood ; Edhi, Muhammad Muzzammil ; Ali, Javaria Parwez ; Hashmi, Shumaila Kanwal ; Asif, Huda ; Faridi, Naveen ; Khan, Amir

BMC research notes, 2019-09, Vol.12 (1), p.605-605, Article 605 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Material Type:
Artigo 		Adicionar ao Meu Espaço

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Ibrahim, Sherif Abdelaziz ; Gadalla, Ramy ; El-Ghonaimy, Eslam A ; Samir, Omnia ; Mohamed, Hossam Taha ; Hassan, Hebatallah ; Greve, Burkhard ; El-Shinawi, Mohamed ; Mohamed, Mona Mostafa ; Götte, Martin

Molecular cancer, 2017-03, Vol.16 (1), p.57-57, Article 57 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
9
Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013
Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013

Shoemaker, Meredith L. ; White, Mary C. ; Wu, Manxia ; Weir, Hannah K. ; Romieu, Isabelle

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.595-606 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
10
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial

Wang, Xi ; Wang, Shu-Sen ; Huang, Heng ; Cai, Li ; Zhao, Li ; Peng, Rou-Jun ; Lin, Ying ; Tang, Jun ; Zeng, Jian ; Zhang, Le-Hong ; Ke, Yong-Li ; Wang, Xian-Ming ; Liu, Xin-Mei ; Chen, Qian-Jun ; Zhang, An-Qin ; Xu, Fei ; Bi, Xi-Wen ; Huang, Jia-Jia ; Li, Ji-Bin ; Pang, Dan-Mei ; Xue, Cong ; Shi, Yan-Xia ; He, Zhen-Yu ; Lin, Huan-Xin ; An, Xin ; Xia, Wen ; Cao, Ye ; Guo, Ying ; Su, Yan-Hong ; Hua, Xin ; Wang, Xin-Yue ; Hong, Ruo-Xi ; Jiang, Kui-Kui ; Song, Chen-Ge ; Huang, Zhang-Zan ; Shi, Wei ; Zhong, Yong-Yi ; Yuan, Zhong-Yu

JAMA : the journal of the American Medical Association, 2021-01, Vol.325 (1), p.50-58 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.520)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.551)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1995  (7)
  2. 1995Até2003  (12)
  3. 2004Até2010  (13)
  4. 2011Até2018  (1.308)
  5. Após 2018  (213)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.550)
  2. Japonês  (262)
  3. Alemão  (2)
  4. Português  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.